Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of LY4005130 in adults with severe alopecia areata
CTR20262701Phase 2Active
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2026
- Countries
- 1
01
Overview
A Phase 2 trial of LY4005130 in alopecia areata, sponsored by Eli Lilly and Company. Started Aug 2026; status: active.
02
Drugs
LY4005130
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20262701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262701.